The need for regulation in the practice of human assisted reproduction in Mexico. An overview of the regulations in the rest of the world

Plain language summary The emergence of ART in humans has been an important tool for the treatment of infertility. It is reported that one in four couples in developing countries has fertility problems. In 2009, the International Committee for Monitoring Assisted Reproductive Technology (ICMART) established ART as "all treatments or procedures involving in vitro manipulation of oocytes, sperm or embryos for the purpose of establishing a pregnancy". The number of treatments performed in Latin America has been increasing, and Mexico is the third country with the most assisted reproduction cycles performed in the region. However, Mexico lacks a national regulation for human assisted reproduction. This has caused Mexico to become a medical tourism paradise, which increases the possibility of abuses, fraud, and clinical risks. In addition, it allows each institution offering assisted reproduction services, whether public or private, to establish arbitrary requirements for inclusion. Thus, the emergence of a regulation that allows a safe clinical practice based on ethics, which will also make this reproductive tool available to any social group, is a social need. Therefore, the aim of this review was to examine the existing legislation that regulates human assisted reproduction practices in Mexico, but also to examine the legal analysis of the policies, laws, and regulations in use in some countries in Latin America, North America, and Europe, as well as highlighting the importance of working on the establishment of regulations that allow for safe and ethically based clinical practices.